Pharma News

Odevixibat by Ipsen for Biliary Atresia: Likelihood of Approval

Photo of MEEFRO MEEFRO Send an email March 18, 2024
0 124,533 Less than a minute

Odevixibat is under clinical development by Ipsen and currently in Phase III for Biliary Atresia.

Source link
#Odevixibat #Ipsen #Biliary #Atresia #Likelihood #Approval

Photo of MEEFRO MEEFRO Send an email March 18, 2024
0 124,533 Less than a minute
Photo of MEEFRO

MEEFRO

Related Articles

What is the current valuation of AstraZeneca’s Sabestomig

April 16, 2024

What is the current valuation of AbbVie’s ABBV-400

April 16, 2024

What is the current valuation of Merck’s MK-1084

April 16, 2024

What is the current valuation of AstraZeneca’s AZD-9574

April 16, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *